SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Mar-24 5:50 PM View: | Abbvie Inc. (ABBV) | 29-Feb-24 | Option Exercise | 21,560 | $58.30 | $1,257,010.00 | 15% 145.96K to 167.52K | |
01-Mar-24 5:50 PM View: | Abbvie Inc. (ABBV) | 29-Feb-24 | Option Sale | 21,560 | $176.45 | $3,804,340.00 | (13%) 167.52K to 145.96K | |
01-Mar-24 5:50 PM View: | Abbvie Inc. (ABBV) | 29-Feb-24 | Sale | 47,319 | $176.45 | $8,349,620.00 | (32%) 145.96K to 98.64K | |
01-Mar-24 5:50 PM View: | Abbvie Inc. (ABBV) | 28-Feb-24 | Payment of Exercise | 37,638 | $178.99 | $6,736,830.00 | (20%) 183.6K to 145.96K | |
20-Feb-24 5:15 PM View: | Abbvie Inc. (ABBV) | 15-Feb-24 | Grant | 84,957 | -- | -- | 86% 98.64K to 183.6K | |
02-Mar-23 4:30 PM View: | Abbvie Inc. (ABBV) | 28-Feb-23 | Payment of Exercise | 48,335 | $154.28 | $7,457,120.00 | (33%) 146.98K to 98.64K | |
21-Feb-23 5:59 PM View: | Abbvie Inc. (ABBV) | 16-Feb-23 | Grant | 109,103 | -- | -- | 288% 37.88K to 146.98K | |
01-Mar-22 6:07 PM View: | Abbvie Inc. (ABBV) | 01-Mar-22 | Sale | 43,105 | $148.25 | $6,390,250.00 | (53%) 80.98K to 37.88K | |
01-Mar-22 6:07 PM View: | Abbvie Inc. (ABBV) | 25-Feb-22 | Payment of Exercise | 34,286 | $149.54 | $5,127,130.00 | (30%) 115.27K to 80.98K | |
22-Feb-22 5:39 PM View: | Abbvie Inc. (ABBV) | 17-Feb-22 | Grant | 77,391 | -- | -- | 204% 37.88K to 115.27K | |
02-Mar-21 8:32 PM View: | Abbvie Inc. (ABBV) | 28-Feb-21 | Payment of Exercise | 14,006 | $107.74 | $1,509,010.00 | (27%) 51.88K to 37.88K | (< 1%) |
22-Feb-21 6:25 PM View: | Abbvie Inc. (ABBV) | 18-Feb-21 | Grant | 31,613 | -- | -- | 156% 20.27K to 51.88K | |
03-Mar-20 4:54 PM View: | Abbvie Inc. (ABBV) | 28-Feb-20 | Payment of Exercise | 7,438 | $85.42 | $635,354.00 | (27%) 27.71K to 20.27K | (16%) |
24-Feb-20 6:01 PM View: | Abbvie Inc. (ABBV) | 20-Feb-20 | Grant | 16,795 | -- | -- | 154% 10.91K to 27.71K | |
04-Mar-19 4:56 PM View: | Abbvie Inc. (ABBV) | 28-Feb-19 | Payment of Exercise | 3,206 | $79.41 | $254,588.00 | (23%) 14.12K to 10.91K | (21%) |
22-Feb-19 5:18 PM View: | Abbvie Inc. (ABBV) | 21-Feb-19 | Grant | 7,243 | -- | -- | 105% 6.88K to 14.12K | |
02-Mar-18 10:00 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Payment of Exercise | 2,387 | $118.26 | $282,287.00 | (18%) 13.56K to 11.17K | 20% |
02-Mar-18 10:00 PM View: | Abbvie Inc. (ABBV) | 28-Feb-18 | Market Sale | 4,294 | $119.43 | $512,853.00 | (38%) 11.17K to 6.88K | 21% |
20-Feb-18 6:08 PM View: | Abbvie Inc. (ABBV) | 20-Feb-18 | Market Sale | 992 | $120.31 | $119,351.00 | (7%) 14.55K to 13.56K | 22% |
20-Feb-18 6:08 PM View: | Abbvie Inc. (ABBV) | 19-Feb-18 | Payment of Exercise | 838 | $118.60 | $99,386.80 | (5%) 15.39K to 14.55K | 21% |
16-Feb-18 5:56 PM View: | Abbvie Inc. (ABBV) | 15-Feb-18 | Grant | 5,380 | -- | -- | 54% 10.01K to 15.39K | |
29-Sep-17 5:02 PM View: | Abbvie Inc. (ABBV) | 28-Sep-17 | Market Sale | 6,699 | $88.00 | $589,512.00 | (40%) 16.71K to 10.01K | (6%) |
10-Mar-17 5:22 PM View: | Abbvie Inc. (ABBV) | 10-Mar-17 | Market Sale | 5,132 | $65.29 | $335,068.00 | (24%) 21.84K to 16.71K | (40%) |